Literature DB >> 3514345

Direct metabolic effects of gastric inhibitory polypeptide (GIP): dissociation at physiological levels of effects on insulin-stimulated fatty acid and glucose incorporation in rat adipose tissue.

B Beck, J P Max.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3514345     DOI： 10.1007/bf02427284

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  6 in total

1.  A micro-method for determination of fatty acid (FIAT) and glucose (GLIAT) incorporation and lipolysis in vitro in needle biopsies of human adipose tissue.

Authors:  G Walldius; P Rubba
Journal:  Scand J Clin Lab Invest       Date:  1976-07       Impact factor: 1.713

Review 2.  New developments in the incretin concept.

Authors:  W Creutzfeldt; R Ebert
Journal:  Diabetologia       Date:  1985-08       Impact factor: 10.122

3.  Effect of gastric inhibitory polypeptide on plasma levels of chylomicron triglycerides in dogs.

Authors:  T Wasada; K McCorkle; V Harris; K Kawai; B Howard; R H Unger
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

4.  Effects of medium- and long-chain triacylglycerols on adipose tissue metabolism in the obese Zucker rat.

Authors:  J P Max; A Bach; E Pallier; H Schirardin; G Debry
Journal:  Int J Obes       Date:  1983

5.  Gastric inhibitory polypeptide enhancement of the insulin effect on fatty acid incorporation into adipose tissue in the rat.

Authors:  B Beck; J P Max
Journal:  Regul Pept       Date:  1983-09

6.  Gastric inhibitory polypeptide enhanced lipoprotein lipase activity in cultured preadipocytes.

Authors:  R H Eckel; W Y Fujimoto; J D Brunzell
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461
  6 in total
  5 in total

1.  GIP increases human adipocyte LPL expression through CREB and TORC2-mediated trans-activation of the LPL gene.

Authors:  Su-Jin Kim; Cuilan Nian; Christopher H S McIntosh
Journal:  J Lipid Res       Date:  2010-08-07       Impact factor: 5.922

Review 2.  Glucose-dependent insulinotropic polypeptide signaling in pancreatic β-cells and adipocytes.

Authors:  Christopher Hs McIntosh; Scott Widenmaier; Su-Jin Kim
Journal:  J Diabetes Investig       Date:  2012-03-28       Impact factor: 4.232

3.  The glucose-dependent insulinotropic polypeptide (GIP) regulates body weight and food intake via CNS-GIPR signaling.

Authors:  Qian Zhang; Challa Tenagne Delessa; Robert Augustin; Mostafa Bakhti; Gustav Colldén; Daniel J Drucker; Annette Feuchtinger; Cristina Garcia Caceres; Gerald Grandl; Alexandra Harger; Stephan Herzig; Susanna Hofmann; Cassie Lynn Holleman; Martin Jastroch; Susanne Keipert; Maximilian Kleinert; Patrick J Knerr; Konxhe Kulaj; Beata Legutko; Heiko Lickert; Xue Liu; Gerd Luippold; Dominik Lutter; Emilija Malogajski; Marta Tarquis Medina; Stephanie A Mowery; Andreas Blutke; Diego Perez-Tilve; Ciro Salinno; Laura Sehrer; Richard D DiMarchi; Matthias H Tschöp; Kerstin Stemmer; Brian Finan; Christian Wolfrum; Timo D Müller
Journal:  Cell Metab       Date:  2021-02-10       Impact factor: 27.287

4.  GIPR antagonist antibodies conjugated to GLP-1 peptide are bispecific molecules that decrease weight in obese mice and monkeys.

Authors:  Shu-Chen Lu; Michelle Chen; Larissa Atangan; Elizabeth A Killion; Renee Komorowski; Yuan Cheng; Chawita Netirojjanakul; James R Falsey; Marina Stolina; Denise Dwyer; Clarence Hale; Shanaka Stanislaus; Todd Hager; Veena A Thomas; John M Harrold; David J Lloyd; Murielle M Véniant
Journal:  Cell Rep Med       Date:  2021-04-30

5.  Molecular mechanism of an antagonistic antibody against glucose-dependent insulinotropic polypeptide receptor.

Authors:  Xiaoshan Min; Junming Yie; Jinghong Wang; Ben C Chung; Ching-Shin Huang; Haoda Xu; Jie Yang; Liying Deng; Joanne Lin; Qing Chen; Christina M Abbott; Caroline Gundel; Stephen A Thibault; Tina Meng; Darren L Bates; David J Lloyd; Murielle M Véniant; Zhulun Wang
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.